ASEMtech Raises 150 Million Yen in Series A Extension
ASEMtech raised 150 million yen in a Series A extension, reaching a total of 400 million yen. The funds will accelerate the social implementation of their ultrasound-based electromagnetic visualization technology (ASEM method) in medical and industrial fields.
📋 Article Processing Timeline
- 📰 Published: April 3, 2026 at 01:10
- 🔍 Collected: April 2, 2026 at 19:35
- 🤖 AI Analyzed: April 21, 2026 at 07:05 (443h 29m after Collected)
ASEMtech Inc. (Headquarters: Koganei City, Tokyo; Representative Directors: Kenji Ikushima, Nobuo Niimi; hereinafter "ASEMtech"), which aims for the social implementation of the Acoustically Stimulated Electromagnetic (ASEM) method, a technology for visualizing electricity and magnetism using ultrasound, raised a total of 150 million yen through third-party allotment of shares in a Series A extension round conducted in March 2026. Combined with the 250 million yen raised in the Series A round in April 2025, the company has achieved a cumulative total of 400 million yen in funding for the entire Series A round.
Participating in this round are Hanno Shinkin Bank, Tama Shinkin Bank, BP Capital Co., Ltd. (Tokyo University of Agriculture and Technology TUAT No. 1 Fund), and Leo Electronics Co., Ltd.
Accelerating Initiatives with this Funding
With this funding, ASEMtech will further advance the following key developments in both the medical and industrial fields:
1. Completion of a prototype and initiation of clinical research at a university hospital
A medical device prototype using the ASEM method has been completed, and clinical research targeting locomotor disorders has begun at a university hospital. This marks the full-scale verification of the clinical utility of the world's first technology to non-invasively visualize the accumulation and orientation of collagen fibers.
2. Acquisition of Class II Medical Device Manufacturing and Sales Business License
The company has advanced the establishment of a system for regulatory application and acquired a Class II medical device manufacturing and sales license. This represents a major step forward in the development and quality management system toward commercialization as a medical device.
3. Initiation of discussions on overseas expansion with medical institutions in Singapore
Toward the international expansion of the ASEM method, the company has begun discussions on joint research and clinical introduction with medical institutions in Singapore. It is building a foundation for overseas expansion to meet medical needs in the Asian region.
4. Full-scale launch of the industrial non-destructive testing business and commencement of product sales in the steel, materials, and infrastructure sectors
The industrial non-destructive testing equipment developed during the seed stage has already been launched as a business, with sales starting for applications aimed at steel and material inspection and infrastructure maintenance. Moving forward, the company will expand its customer base in the industrial sector and strengthen its product lineup to meet diverse client needs.
Comments from Kenji Ikushima, Representative of ASEMtech Inc.
ASEMtech aims to provide innovative solutions in the medical/healthcare and industrial sectors, centered on the "ASEM method," an ultrasound-based electrical and magnetic visualization technology.
In this funding round, we are pleased to welcome new investments from Hanno Shinkin Bank and Tama Shinkin Bank, alongside additional investments from our existing investors, BP Capital and Leo Electronics. With the support of regional financial institutions, we will further strengthen our collaboration with local companies, primarily in the Tama and West Saitama areas, and accelerate value creation as a locally-born advanced technology.
Taking this funding as an opportunity, we will further accelerate clinical research targeting locomotor disorders, fully prepare for regulatory applications as a medical device, and actively expand the market for industrial non-destructive testing equipment aimed at steel inspection and infrastructure maintenance.
Participating in this round are Hanno Shinkin Bank, Tama Shinkin Bank, BP Capital Co., Ltd. (Tokyo University of Agriculture and Technology TUAT No. 1 Fund), and Leo Electronics Co., Ltd.
Accelerating Initiatives with this Funding
With this funding, ASEMtech will further advance the following key developments in both the medical and industrial fields:
1. Completion of a prototype and initiation of clinical research at a university hospital
A medical device prototype using the ASEM method has been completed, and clinical research targeting locomotor disorders has begun at a university hospital. This marks the full-scale verification of the clinical utility of the world's first technology to non-invasively visualize the accumulation and orientation of collagen fibers.
2. Acquisition of Class II Medical Device Manufacturing and Sales Business License
The company has advanced the establishment of a system for regulatory application and acquired a Class II medical device manufacturing and sales license. This represents a major step forward in the development and quality management system toward commercialization as a medical device.
3. Initiation of discussions on overseas expansion with medical institutions in Singapore
Toward the international expansion of the ASEM method, the company has begun discussions on joint research and clinical introduction with medical institutions in Singapore. It is building a foundation for overseas expansion to meet medical needs in the Asian region.
4. Full-scale launch of the industrial non-destructive testing business and commencement of product sales in the steel, materials, and infrastructure sectors
The industrial non-destructive testing equipment developed during the seed stage has already been launched as a business, with sales starting for applications aimed at steel and material inspection and infrastructure maintenance. Moving forward, the company will expand its customer base in the industrial sector and strengthen its product lineup to meet diverse client needs.
Comments from Kenji Ikushima, Representative of ASEMtech Inc.
ASEMtech aims to provide innovative solutions in the medical/healthcare and industrial sectors, centered on the "ASEM method," an ultrasound-based electrical and magnetic visualization technology.
In this funding round, we are pleased to welcome new investments from Hanno Shinkin Bank and Tama Shinkin Bank, alongside additional investments from our existing investors, BP Capital and Leo Electronics. With the support of regional financial institutions, we will further strengthen our collaboration with local companies, primarily in the Tama and West Saitama areas, and accelerate value creation as a locally-born advanced technology.
Taking this funding as an opportunity, we will further accelerate clinical research targeting locomotor disorders, fully prepare for regulatory applications as a medical device, and actively expand the market for industrial non-destructive testing equipment aimed at steel inspection and infrastructure maintenance.